NEW YORK— British drugmaker GlaxoSmithKline is looking into allegations of bribery within its operations in Jordan and Lebanon. On Monday the BBC reported that GlaxoSmithKline PLC is facing a bribery investigation in Poland, where a sales representative allegedly paid doctors to prescribe the company's asthma drug Seretide.» Read More
CNBC's Brian Sullivan and Amanda Drury share their gloomy and sunny stock picks, including Lowe's falling 10% and Wal-Mart hitting a new 52-week high amid investigations over a reported bribery.
CNBC's Brian Shactman reports on an unusual black market which some say is worth $20 billion each year.
Should the U.S. government be prosecuting companies that pay bribes in order to get business done in foreign countries? Jeffrey Miron, Harvard University and Alexandra Wrage, Trace International, weigh in.
There's more fallout from the allegations that Wal-Mart used bribery to spur expansion in Mexico. A group of New York City pension funds will vote their 4.7 million shares against five Wal-Mart directors standing for re-election at the company's annual shareholder meeting. John Liu, New York City comptroller and trustee of the city pension funds, weighs in.
In Los Angeles, a Wal-Mart building permit is getting a once-over. In New York, the City Council is investigating a possible land deal with the retailer’s developer in Brooklyn. A state senator in California is pushing for a formal audit of a proposed Wal-Mart in San Diego. And in Boston and its suburbs, residents are pressuring politicians to disclose whether they have received contributions from the company, the New York Times reports.
CNBC's Michelle Caruso-Cabrera reports on a threat to the Wal-Mart investigation to look at every permit the company issued.
CNBC's Michelle Caruso-Cabrera reports the latest details on the bribery allegations coming from Wal-Mart's Mexican division, Walmex.
Jeffrey Sonnenfeld,Yale School of Management and William George, Harvard Business School professor discuss recent headlines highlighting scandals and bribery at several big American companies.
CNBC's Eamon Javers reports on Bristol-Meyers receiving a subpoena from the SEC. Also, Avon Group's Vice President Kerry Carr is resigning amid allegations of a bribery in China.
CNBC's Michelle Caruso-Cabrera reports on the latest details of the alleged bribery scandal.
Take our poll and and let us know which, if any, of these scenarios you would bribe your way out of.
The elephant in the room in the wake of the Wal-Mart spacer fiasco is whether we should accept, cover-up or no cover-up, the concept of bribes, graft and outright corruption as simply a way of doing business abroad? Herb Greenberg examines.
There is no clear evidence bribes were made to get a Wal-Mart store built built in Teotihuacan, near ancient pyramids in Mexico, reports CNBC's Michelle Caruso-Cabrera.
CNBC's Courtney Reagan reports on Wal-Mart's response to the New York Times article on the company's alleged bribery.
Whitney Tilson, T2 Partners, says the Netflix earnings report was "great news." He also weighs in on the alleged Wal-Mart scandal, currently under investigation.
CNBC's Michelle Caruso-Cabrera and Mary Thompson discuss the Wal-Mart investigation underway since the company got hit with bribery accusations in Mexico.
Analysts say as long as key U.S. same-store sales continue to grow, Wal-Mart could get a pass from investors, reports CNBC's Courtney Reagan.
Carter Worth, Oppenheimer chief market technician, explains whether a slide in Wal-Mart shares today signals a buying opportunity for investors.
The Wal-Mart corruption scandal is pushing the stock sharply lower today. CNBC's Eamon Javers offers insight from Washington.
CNBC's Scott Cohn discusses how the Foreign Corrupt Practices Act applies to Wal-Mart's alleged $24M in bribes to Mexican officials. Robert Shapiro, Sonecon chairman & co-founder, also weighs in.